<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; CYNO</title>
	<atom:link href="http://www.stockbloghub.com/tag/cyno/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CUTR) Cutera&#8217;s GenesisPlus Laser Cleared</title>
		<link>http://www.stockbloghub.com/2011/04/13/cutr-cuteras-genesisplus-laser-cleared/71350</link>
		<comments>http://www.stockbloghub.com/2011/04/13/cutr-cuteras-genesisplus-laser-cleared/71350#comments</comments>
		<pubDate>Wed, 13 Apr 2011 17:12:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cutera Inc]]></category>
		<category><![CDATA[CUTR]]></category>
		<category><![CDATA[CYNO]]></category>
		<category><![CDATA[Cynosure Inc]]></category>
		<category><![CDATA[ELOS]]></category>
		<category><![CDATA[Palomar Medical Technologies Inc]]></category>
		<category><![CDATA[PMTI]]></category>
		<category><![CDATA[Syneron Medical Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71350</guid>
		<description><![CDATA[Medical devices maker Cutera Inc (CUTR) has obtained the 510 (k) clearance from the U.S. Food and Drug Administration (“FDA”) for its GenesisPlus laser for treating onychomycosis (nail fungus). The California-based company’s shares spiked following the news of the approval. Onychomycosis, a fungal infection of the toenails or fingernails, afflicts roughly 35 million Americans. The condition represents clinical symptoms such as discoloration/ thickening of the nail and separation of the nail plate from the nail bed. It is more likely to develop in people with conditions such as diabetes, psoriasis, and peripheral arterial disease (“PAD”). The worldwide market for onychomycosis therapies is estimated to be more than $2 billion. Roughly 20% of the people affected with onychomycosis seek treatment annually in the U.S. Despite its wide prevalence, there are limited ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/cutr-cuteras-genesisplus-laser-cleared/71350/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CYNO) Buy “Low-Density” &#8211; How to Take the Guesswork Out of Valuing Stocks</title>
		<link>http://www.stockbloghub.com/2009/08/26/cyno-buy-%e2%80%9clow-density%e2%80%9d-how-to-take-the-guesswork-out-of-valuing-stocks/13415</link>
		<comments>http://www.stockbloghub.com/2009/08/26/cyno-buy-%e2%80%9clow-density%e2%80%9d-how-to-take-the-guesswork-out-of-valuing-stocks/13415#comments</comments>
		<pubDate>Wed, 26 Aug 2009 15:57:49 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BRCM]]></category>
		<category><![CDATA[Broadcom Corp.]]></category>
		<category><![CDATA[CYNO]]></category>
		<category><![CDATA[Cynosure Inc]]></category>
		<category><![CDATA[TRID]]></category>
		<category><![CDATA[Trident Microsystems Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13415</guid>
		<description><![CDATA[by Louis Basenese, Advisory Panelist I don’t care what investing legend you idolize and try to emulate – Buffett, Graham, Rogers, Lynch – they all share a common recommendation. Always buy undervalued stocks and sell them when they’re overvalued. Or more commonly: “Buy low, sell high.” Of course, if you’ve invested for more than a week, you know this is easier said than done. Undervalued (cheap) and overvalued (expensive) are such subjective measures when it comes to investing. Most times we end up guessing and most times we end up overpaying. But today, let me show you one amazingly simple way to always buy stocks that are truly cheap… Why America’s Most Successful Investors Buy “Low-Density” Stocks All you have to do in order to invest like Warren Buffett, or ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/26/cyno-buy-%e2%80%9clow-density%e2%80%9d-how-to-take-the-guesswork-out-of-valuing-stocks/13415/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

